Secondary Antibodies

Recombinant protein fragment of Human CDR2 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human CDR2L with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen CDR2L cerebellar degeneration-related protein

Recombinant protein fragment of Human CDS2 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human CDX2&nbspwith&nbspN-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag.&nbsp &nbsp&nbsp Application Blocking agent and positive assay control using

Recombinant protein fragment of Human CDX2&nbspwith&nbspN-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag.&nbsp &nbsp&nbsp Application Blocking agent and positive assay control using

N-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) Application Suitable as a blocking agent and positive assay control using corresponding antibodies. Linkage Corresponding Antibodies HPA066682 Physical form

PrEST Antigen CDY2B chromodomain Y-linked 2B, 100ul UN 1687

Recombinant protein fragment of Human CDYL2 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen CDYL2 chromodomain protein, Y-like 2, 100ul UN

PrEST Antigen CECR1 cat eye syndrome chromosome region, cand

Recombinant protein fragment of Human CECR2 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.